WBCPC Presents at ASCO GU 2026 in San Francisco

The World Bladder Cancer Patient Coalition (WBCPC) took part in the 2026 edition of the ASCO Genitourinary Cancers Symposium, held in San Francisco from February 27–29, 2026. This international meeting brings together clinicians, researchers and organisations working in genitourinary (GU) cancers, including bladder cancer, to share the latest scientific developments and clinical updates.

This year, our Executive Director, Alex Filicevas, presented a poster titled: “Fostering Inclusive Language in Genitourinary Cancer Research” during the Prostate Cancer and Urothelial Carcinoma session.

The poster addresses an important question: bladder cancer research is advancing but are we making it accessible enough for patients?

The project presented at ASCO GU focuses on developing a plain language lexicon for bladder cancer and prostate cancer. In total, 146 commonly used medical terms were reviewed and refined through collaboration between patients, patient advocates, clinicians and researchers. The objective was to explain complex medical terms in clearer language without losing scientific accuracy. These lexicons were developed together with Johnson & Johsnon, World Bladder Cancer Patient Coalition and Prostate Health Education Network.

For people living with bladder cancer, understanding medical terminology is not a minor issue. Words such as “radical cystectomy”, “intravesical therapy” or “surveillance” directly affect how patients understand their diagnosis, evaluate treatment options and take part in decisions about their care. When language is unclear, patients may feel confused or excluded from important conversations. When explanations are clear, patients are better prepared to ask questions and engage in shared decision-making.